BLOCADREN, created in 1972 (Japan), from 33 sister brands and 17477 competing brands. BLOCADREN is a brand of Santen Pharmaceutical, listed on the stock exchange of Francfort. The International Securities Identification Number (ISIN) of Santen Pharmaceutical is JP3336000009. BLOCADREN belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Santen Pharmaceutical
(BLOCADREN)
over 5 years*
EUR 5.79